Trial · NCT07890194
Effectiveness of Individualized Pelvic Floor Muscle Rehabilitation in Addition to Standard Urotherapy and Alarm Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis
NCT07890194, Not applicable, Recruiting, Hacettepe University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effectiveness of Individualized Pelvic Floor Muscle Rehabilitation in Addition to Standard Urotherapy and Alarm Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis. Trials, record NCT07890194. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07890194
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effectiveness of Individualized Pelvic Floor Muscle Rehabilitation in Addition to Standard Urotherapy and Alarm Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis
- NCT number
- NCT07890194
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 30 participants, estimated
- Lead sponsor
- Hacettepe University
- Conditions
- Primary Monosymptomatic Nocturnal Enuresis
- Interventions
- Standard urotherapy, Alarm therapy, Standard urotherapy, Alarm therapy, Individualized pelvic floor muscle rehabilitation
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Dry Nights | Baseline and weeks 4, 8, and 12. | The number of nights without involuntary urine leakage during sleep will be recorded by parents using an enuresis diary. |
| Primary | Number of Enuresis Alarm Activations | Baseline and weeks 4, 8, and 12. | The number of moisture-triggered enuresis alarm activations during sleep will be recorded by parents using an enuresis diary. |
| Secondary | Treatment Response According to ICCS Criteria | Baseline and weeks 12. | Treatment response will be classified according to the percentage reduction in wet nights from baseline: no response (\<50% reduction), partial response (50-99% reduction), or complete response (100% reduction). |
| Secondary | Dysfunctional Voiding and Incontinence Scoring System (DVISS) Score | Baseline and weeks 4, 8, and 12. | Urinary symptoms and their impact on quality of life will be assessed using the DVISS. Total scores range from 0 to 35, with higher scores indicating greater symptom severity. |
| Secondary | Nocturnal Enuresis Symptom Score (NESS) | Baseline and weeks 4, 8, and 12. | The severity of nocturnal enuresis symptoms will be assessed using the Nocturnal Enuresis Symptom Score (NESS). Total scores range from 0 to 27, with higher scores indicating greater symptom severi |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07890194
GET https://conductscience.org/api/trials/v1/NCT07890194/registered